1. P462 Impact of teduglutide, a GLP-2 agonist, on inflammatory bowel disease-associated short bowel syndrome: a tertiary single-center study. (27th May 2021) Authors: de Seze, M; Billiauws, L; Bettolo, J; Damas, V; Hutinet, C; Bonvalet, F; Cazals-Hatem, D; Villain, C; Bouhnik, Y; Joly, F; Uzzan, M Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S454 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗